Literature DB >> 20877293

Vaccine outlooks. After negative publicity and a series of setbacks over HIV/AIDS and influenza, the prospects for research on new vaccines are improving.

Philip Hunter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20877293      PMCID： PMC2948189          DOI： 10.1038/embor.2010.136

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  5 in total

1.  HIV vaccine failure prompts Merck to halt trial.

Authors: 
Journal:  Nature       Date:  2007-09-27       Impact factor: 49.962

Review 2.  Progress towards a dengue vaccine.

Authors:  Daniel P Webster; Jeremy Farrar; Sarah Rowland-Jones
Journal:  Lancet Infect Dis       Date:  2009-11       Impact factor: 25.071

3.  HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva. The NIAID AIDS Vaccine Clinical Trials Network.

Authors:  G J Gorse; J H Rogers; J E Perry; F K Newman; S E Frey; G B Patel; R B Belshe
Journal:  Vaccine       Date:  1995-02       Impact factor: 3.641

4.  Live attenuated influenza virus vaccines by computer-aided rational design.

Authors:  Steffen Mueller; J Robert Coleman; Dimitris Papamichail; Charles B Ward; Anjaruwee Nimnual; Bruce Futcher; Steven Skiena; Eckard Wimmer
Journal:  Nat Biotechnol       Date:  2010-06-13       Impact factor: 54.908

5.  Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

Authors:  Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Joseph Chiu; Robert Paris; Nakorn Premsri; Chawetsan Namwat; Mark de Souza; Elizabeth Adams; Michael Benenson; Sanjay Gurunathan; Jim Tartaglia; John G McNeil; Donald P Francis; Donald Stablein; Deborah L Birx; Supamit Chunsuttiwat; Chirasak Khamboonruang; Prasert Thongcharoen; Merlin L Robb; Nelson L Michael; Prayura Kunasol; Jerome H Kim
Journal:  N Engl J Med       Date:  2009-10-20       Impact factor: 91.245
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.